We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Disseminated intravascular coagulation.
The diagnosis of disseminated intravascular coagulation (DIC) was initially based on the detection of microthrombi. Current diagnosis involves laboratory assessment of hemostatic abnormalities although additional studies may often be necessary. DIC is characterized by hypercoagulability and hyperfibrinolysis and is caused by high offense factors or low defense factors. DIC is divided two stages: overt-DIC and non-overt-DIC. The diagnosis of overt-DIC state is based on the criteria developed by the International Society of Thrombosis Haemostasis in conjunction with the Japanese Ministry Health and Welfare. However, no criteria are currently available for the diagnosis of non-overt DIC. Although scientifically supported modalities for treatment of DIC are few, the use of activated protein C (APC) and low-molecular-weight heparin appear to hold promise.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app